其他血液恶性肿瘤的临床试验
总计12696个结果
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma US, Inc.完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人
-
M.D. Anderson Cancer Center暂停
-
National Cancer Institute (NCI)邀请报名
-
Cancer Research UKRoyal Marsden NHS Foundation Trust; Hoffmann-La Roche; University of Manchester; University of Birmingham招聘中
-
Bellicum Pharmaceuticals撤销骨髓增生异常综合征 | 白血病 | 多发性骨髓瘤 | 淋巴瘤 | 其他高危血液系统恶性肿瘤
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)终止
-
Novartis Pharmaceuticals完全的
-
University Hospital, Grenoble完全的
-
University of Southern CaliforniaNational Cancer Institute (NCI)招聘中
-
Florin Iordache完全的Bacterium-Related Malignant Neoplasm
-
Miltenyi Biomedicine GmbHCity of Hope Comprehensive Cancer Center尚未招聘血液系统恶性肿瘤
-
Merck Sharp & Dohme LLC主动,不招人血液系统恶性肿瘤美国, 加拿大, 巴西, 智利, 丹麦, 法国, 德国, 匈牙利, 以色列, 意大利, 波兰, 俄罗斯联邦, 西班牙, 台湾, 火鸡, 乌克兰
-
Merck Sharp & Dohme LLC主动,不招人
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and Development; Dutch Cancer Society完全的
-
University of PaviaFondazione Salvatore Maugeri; IRCCS Policlinico S. Matteo未知
-
Methodist Health System招聘中
-
University of Southern CaliforniaNational Cancer Institute (NCI)完全的
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)终止
-
Matthew DallosBristol-Myers Squibb终止